Plans-Rubió, P, Pericas, C, Avellon, AM, Izquierdo, C, Martínez, A, Torner, N, Martínez, A, Borras, E, Roig, F, Godoy, P, Rius, C. Healthcare and Epidemiological Surveillance Costs of Hepatitis A Outbreaks in Spain in Regions with and without Universal Hepatitis A Vaccination of Children during 2010-2018. Vaccines. 2024; 12(6)DOI:10.3390/vaccines12060648. PMID:38932377. IF:3.400(Q2/4D).

Ullmo, J, Cruz-Lemini, M, Lidia, B, Mireia, P, Barbarà, MC, Martorell, S, Clivillé, DB, Gallardo, CD, Gimenez, CG, Trilla, C, García, OS, Costa, FC, Sionis, A, Mora, J, Osuna, AG, Ordoñez, J, Llurba, E. Early cardiac function in women with and without high-risk of preeclampsia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Fraga, G, Herreros, MA, Pybus, M, Aza-Carmona, M, Pilco-Teran, M, Furlano, M, García-Borau, MJ, Torra, R, Ars, E. A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene. Genes. 2024; 15(6)DOI:10.3390/genes15060679. PMID:38927615. IF:2.800(Q2/5D).

Carabante, MIB, Bueno, D, García, LA, Torija, IL, Marsal, J, Navarro, JMF, Oficialdegui, MLU, Panesso, M, Molina, B, Bieler, CB, Palomo, P, Martinez, AP, Diaz-de-Heredia, C. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC). Transplantation And Cellular Therapy. 2024; 30(6)DOI:10.1016/j.jtct.2024.03.019. PMID:38521410. IF:4.400(Q1/1D).

Moura, DS, Varela, JAC, Alvarez, R, Pujol, CA, Izquierdo, F, Ramos, R, Ortega, L, Martin-Davila, F, Leon, NH, Romagosa, C, Vaz-Salgado, MA, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Mondaza-Hernandez, JL, Renshaw-Calderon, M, Hindi, N, Morales, CV, Martínez-Trufero, J, Broto, JM. Predictive gene signature for trabectedin efficacy in advanced soft-tissue sarcoma: A Spanish group for research in sarcoma (GEIS) study. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).

Rodríguez, EG, Renom, PC, Puíg, N, León, AF, Simón, AA, Amaro, AB, Solé, A, Vilades, D, Quesada, JLS, Fábregas, JM, Xarrié, EJ, Benitez, S, Cortés, VL. Soluble low- density lipoprotein receptor-related protein 1 as a marker of carotid plaque inflammation in patients with a recent ischemic stroke. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Gomis-Pastor, M, Berdún, J, Borrás-Santos, A, López, AD, Rama, BFM, García-Esquirol, O, Gratacòs, M, Rodríguez, GDO, Cruz, RP, Real, J, Ferrer, JBI, Comella, A. Clinical Validation of Digital Healthcare Solutions: State of the Art, Challenges and Opportunities. Healthcare. 2024; 12(11)DOI:10.3390/healthcare12111057. PMID:38891132. IF:2.700(Q2/4D).

Burgos, A, Calleja, T, Ibáñez, C, Valencia, CM, Orallo, C, Titos, JC, Conde, D, Diaz, S, Matilla, B, Lizeaga, G, Sánchez, C, Pozo, JFM, Jimenez, S, Jiménez, I, Díez, R, Garrido, M, Larrosa, M, Martinez, MJ, Moreno, E, Campelo, RG. First-line pembrolizumab for lung cancer in a Spanish real-world study.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).